Personalized Cancer Medicine
Personalized Cancer Medicine market is segmented by region (country), players, by Type and by App ... Read More
1 Study Coverage 1.1 Risedronate Product Introduction 1.2 Global Risedronate Outlook 2017 VS 2022 VS 2028 1.2.1 Global Risedronate Sales in US$ Million for the Year 2017-2028 1.2.2 Global Risedronate Sales in Volume for the Year 2017-2028 1.3 United States Risedronate Outlook 2017 VS 2022 VS 2028 1.3.1 United States Risedronate Sales in US$ Million for the Year 2017-2028 1.3.2 United States Risedronate Sales in Volume for the Year 2017-2028 1.4 Risedronate Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.4.1 The Market Share of United States Risedronate in Global, 2017 VS 2022 VS 2028 1.4.2 The Growth Rate of Risedronate Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.5 Risedronate Market Dynamics 1.5.1 Risedronate Industry Trends 1.5.2 Risedronate Market Drivers 1.5.3 Risedronate Market Challenges 1.5.4 Risedronate Market Restraints 1.6 Study Objectives 1.7 Years Considered 2 Market by Type 2.1 Risedronate Market Segment by Type 2.1.1 5 mg Tablets 2.1.2 35 mg Tablets 2.1.3 75 mg Tablets 2.1.4 150 mg Tablets 2.2 Global Risedronate Market Size by Type 2.2.1 Global Risedronate Sales in Value, by Type (2017, 2022 & 2028) 2.2.2 Global Risedronate Sales in Volume, by Type (2017, 2022 & 2028) 2.2.3 Global Risedronate Average Selling Price (ASP) by Type (2017, 2022 & 2028) 2.3 United States Risedronate Market Size by Type 2.3.1 United States Risedronate Sales in Value, by Type (2017, 2022 & 2028) 2.3.2 United States Risedronate Sales in Volume, by Type (2017, 2022 & 2028) 2.3.3 United States Risedronate Average Selling Price (ASP) by Type (2017, 2022 & 2028) 3 Market by Application 3.1 Risedronate Market Segment by Application 3.1.1 Postmenopausal Osteoporosis 3.1.2 Men with Osteoporosis 3.2 Global Risedronate Market Size by Application 3.2.1 Global Risedronate Sales in Value, by Application (2017, 2022 & 2028) 3.2.2 Global Risedronate Sales in Volume, by Application (2017, 2022 & 2028) 3.3.3 Global Risedronate Average Selling Price (ASP) by Application (2017, 2022 & 2028) 3.3 United States Risedronate Market Size by Application 3.3.1 United States Risedronate Sales in Value, by Application (2017, 2022 & 2028) 3.3.2 United States Risedronate Sales in Volume, by Application (2017, 2022 & 2028) 3.3.3 United States Risedronate Average Selling Price (ASP) by Application (2017, 2022 & 2028) 4 Global Risedronate Competitor Landscape by Company 4.1 Global Risedronate Market Size by Company 4.1.1 Top Global Risedronate Manufacturers Ranked by Revenue (2021) 4.1.2 Global Risedronate Revenue by Manufacturer (2017-2022) 4.1.3 Global Risedronate Sales by Manufacturer (2017-2022) 4.1.4 Global Risedronate Price by Manufacturer (2017-2022) 4.2 Global Risedronate Concentration Ratio (CR) 4.2.1 Risedronate Market Concentration Ratio (CR) (2017-2022) 4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Risedronate in 2021 4.2.3 Global Risedronate Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.3 Global Risedronate Manufacturing Base Distribution, Product Type 4.3.1 Global Risedronate Manufacturers, Headquarters and Distribution of Producing Region 4.3.2 Manufacturers Risedronate Product Type 4.3.3 Date of International Manufacturers Enter into Risedronate Market 4.4 Manufacturers Mergers & Acquisitions, Expansion Plans 4.5 United States Risedronate Market Size by Company 4.5.1 Top Risedronate Players in United States, Ranked by Revenue (2021) 4.5.2 United States Risedronate Revenue by Players (2020, 2021 & 2022) 4.5.3 United States Risedronate Sales by Players (2020, 2021 & 2022) 5 Global Risedronate Market Size by Region 5.1 Global Risedronate Market Size by Region: 2017 VS 2022 VS 2028 5.2 Global Risedronate Market Size in Volume by Region (2017-2028) 5.2.1 Global Risedronate Sales in Volume by Region: 2017-2022 5.2.2 Global Risedronate Sales in Volume Forecast by Region (2023-2028) 5.3 Global Risedronate Market Size in Value by Region (2017-2028) 5.3.1 Global Risedronate Sales in Value by Region: 2017-2022 5.3.2 Global Risedronate Sales in Value by Region: 2023-2028 6 Segment in Region Level & Country Level 6.1 North America 6.1.1 North America Risedronate Market Size YoY Growth 2017-2028 6.1.2 North America Risedronate Market Facts & Figures by Country (2017, 2022 & 2028) 6.1.3 U.S. 6.1.4 Canada 6.2 Asia-Pacific 6.2.1 Asia-Pacific Risedronate Market Size YoY Growth 2017-2028 6.2.2 Asia-Pacific Risedronate Market Facts & Figures by Region (2017, 2022 & 2028) 6.2.3 China 6.2.4 Japan 6.2.5 South Korea 6.2.6 India 6.2.7 Australia 6.2.8 Taiwan 6.2.9 Indonesia 6.2.10 Thailand 6.2.11 Malaysia 6.2.12 Philippines 6.3 Europe 6.3.1 Europe Risedronate Market Size YoY Growth 2017-2028 6.3.2 Europe Risedronate Market Facts & Figures by Country (2017, 2022 & 2028) 6.3.3 Germany 6.3.4 France 6.3.5 U.K. 6.3.6 Italy 6.3.7 Russia 6.4 Latin America 6.4.1 Latin America Risedronate Market Size YoY Growth 2017-2028 6.4.2 Latin America Risedronate Market Facts & Figures by Country (2017, 2022 & 2028) 6.4.3 Mexico 6.4.4 Brazil 6.4.5 Argentina 6.5 Middle East and Africa 6.5.1 Middle East and Africa Risedronate Market Size YoY Growth 2017-2028 6.5.2 Middle East and Africa Risedronate Market Facts & Figures by Country (2017, 2022 & 2028) 6.5.3 Turkey 6.5.4 Saudi Arabia 6.5.5 U.A.E 7 Company Profiles 7.1 Merck 7.1.1 Merck Corporation Information 7.1.2 Merck Description and Business Overview 7.1.3 Merck Risedronate Sales, Revenue and Gross Margin (2017-2022) 7.1.4 Merck Risedronate Products Offered 7.1.5 Merck Recent Development 7.2 Amgen 7.2.1 Amgen Corporation Information 7.2.2 Amgen Description and Business Overview 7.2.3 Amgen Risedronate Sales, Revenue and Gross Margin (2017-2022) 7.2.4 Amgen Risedronate Products Offered 7.2.5 Amgen Recent Development 7.3 Teva 7.3.1 Teva Corporation Information 7.3.2 Teva Description and Business Overview 7.3.3 Teva Risedronate Sales, Revenue and Gross Margin (2017-2022) 7.3.4 Teva Risedronate Products Offered 7.3.5 Teva Recent Development 7.4 Mylan 7.4.1 Mylan Corporation Information 7.4.2 Mylan Description and Business Overview 7.4.3 Mylan Risedronate Sales, Revenue and Gross Margin (2017-2022) 7.4.4 Mylan Risedronate Products Offered 7.4.5 Mylan Recent Development 7.5 Apotex 7.5.1 Apotex Corporation Information 7.5.2 Apotex Description and Business Overview 7.5.3 Apotex Risedronate Sales, Revenue and Gross Margin (2017-2022) 7.5.4 Apotex Risedronate Products Offered 7.5.5 Apotex Recent Development 7.6 Sanofi 7.6.1 Sanofi Corporation Information 7.6.2 Sanofi Description and Business Overview 7.6.3 Sanofi Risedronate Sales, Revenue and Gross Margin (2017-2022) 7.6.4 Sanofi Risedronate Products Offered 7.6.5 Sanofi Recent Development 7.7 Abbott 7.7.1 Abbott Corporation Information 7.7.2 Abbott Description and Business Overview 7.7.3 Abbott Risedronate Sales, Revenue and Gross Margin (2017-2022) 7.7.4 Abbott Risedronate Products Offered 7.7.5 Abbott Recent Development 7.8 Novartis 7.8.1 Novartis Corporation Information 7.8.2 Novartis Description and Business Overview 7.8.3 Novartis Risedronate Sales, Revenue and Gross Margin (2017-2022) 7.8.4 Novartis Risedronate Products Offered 7.8.5 Novartis Recent Development 7.9 Tecoland 7.9.1 Tecoland Corporation Information 7.9.2 Tecoland Description and Business Overview 7.9.3 Tecoland Risedronate Sales, Revenue and Gross Margin (2017-2022) 7.9.4 Tecoland Risedronate Products Offered 7.9.5 Tecoland Recent Development 7.10 Taj Pharmaceuticals 7.10.1 Taj Pharmaceuticals Corporation Information 7.10.2 Taj Pharmaceuticals Description and Business Overview 7.10.3 Taj Pharmaceuticals Risedronate Sales, Revenue and Gross Margin (2017-2022) 7.10.4 Taj Pharmaceuticals Risedronate Products Offered 7.10.5 Taj Pharmaceuticals Recent Development 8 Industry Chain and Sales Channels Analysis 8.1 Risedronate Industry Chain Analysis 8.2 Risedronate Key Raw Materials 8.2.1 Key Raw Materials 8.2.2 Risedronate Distributors 8.3 Risedronate Production Mode & Process 8.4 Risedronate Sales and Marketing 8.4.1 Risedronate Sales Channels 8.4.2 Risedronate Distributors 8.5 Risedronate Customers 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.2 Data Source 10.2 Author Details 10.3 Disclaimer
List of Tables Table 1. Risedronate CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028 Table 2. Risedronate Market Trends Table 3. Risedronate Market Drivers Table 4. Risedronate Market Challenges Table 5. Risedronate Market Restraints Table 6. Global Risedronate Sales by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 7. United States Risedronate Sales by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 8. Global Risedronate Sales by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 9. United States Risedronate Sales by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 10. Top Risedronate Manufacturers in Global Market, Ranking by Revenue (2021) Table 11. Global Risedronate Revenue by Manufacturer, (US$ Million), 2017-2022 Table 12. Global Risedronate Revenue Share by Manufacturer, 2017-2022 Table 13. Global Risedronate Sales by Manufacturer, (MT), 2017-2022 Table 14. Global Risedronate Sales Share by Manufacturer, 2017-2022 Table 15. Global Risedronate Price by Manufacturer (2017-2022) & (USD/Kg) Table 16. Global Risedronate Manufacturers Market Concentration Ratio (CR5 and HHI) Table 17. Global Risedronate by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Risedronate as of 2021) Table 18. Top Players of Risedronate in Global Market, Headquarters and Distribution of Producing Region Table 19. Manufacturers Risedronate Product Type Table 20. Date of International Manufacturers Enter into Risedronate Market Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans Table 22. Top Risedronate Players in United States Market, Ranking by Revenue (2021) Table 23. United States Risedronate Revenue by Players, (US$ Million), 2020, 2021 & 2022 Table 24. United States Risedronate Revenue Share by Players, 2020, 2021 & 2022 Table 25. United States Risedronate Sales by Players, (MT), 2020, 2021 & 2022 Table 26. United States Risedronate Sales Share by Players, 2020, 2021 & 2022 Table 27. Global Risedronate Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 Table 28. Global Risedronate Sales in Volume by Region (2017-2022) & (MT) Table 29. Global Risedronate Sales in Volume Forecast by Region (2023-2028) & (MT) Table 30. Global Risedronate Sales in Value by Region (2017-2022) & (US$ Million) Table 31. Global Risedronate Sales in Value Forecast by Region (2023-2028) & (US$ Million) Table 32. North America Risedronate Sales in Volume by Country (2017-2028) & (MT) Table 33. North America Risedronate Sales in Value by Country (2017-2028) & (US$ Million) Table 34. Asia Pacific Risedronate Sales in Volume by Region (2017-2028) & (MT) Table 35. Asia Pacific Risedronate Sales in Value by Region (2017-2028) & (US$ Million) Table 36. Europe Risedronate Sales in Volume by Country (2017-2028) & (MT) Table 37. Europe Risedronate Sales in Value by Country (2017-2028) & (US$ Million) Table 38. Latin America Risedronate Sales in Volume by Country (2017-2028) & (MT) Table 39. Latin Americaa Risedronate Sales in Value by Country (2017-2028) & (US$ Million) Table 40. Middle East and Africa Risedronate Sales in Volume by Country (2017-2028) & (MT) Table 41. Middle East and Africa Risedronate Sales in Value by Country (2017-2028) & (US$ Million) Table 42. Merck Corporation Information Table 43. Merck Description and Business Overview Table 44. Merck Risedronate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 45. Merck Risedronate Product Table 46. Merck Recent Development Table 47. Amgen Corporation Information Table 48. Amgen Description and Business Overview Table 49. Amgen Risedronate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 50. Amgen Product Table 51. Amgen Recent Development Table 52. Teva Corporation Information Table 53. Teva Description and Business Overview Table 54. Teva Risedronate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 55. Teva Product Table 56. Teva Recent Development Table 57. Mylan Corporation Information Table 58. Mylan Description and Business Overview Table 59. Mylan Risedronate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 60. Mylan Product Table 61. Mylan Recent Development Table 62. Apotex Corporation Information Table 63. Apotex Description and Business Overview Table 64. Apotex Risedronate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 65. Apotex Product Table 66. Apotex Recent Development Table 67. Sanofi Corporation Information Table 68. Sanofi Description and Business Overview Table 69. Sanofi Risedronate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 70. Sanofi Product Table 71. Sanofi Recent Development Table 72. Abbott Corporation Information Table 73. Abbott Description and Business Overview Table 74. Abbott Risedronate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 75. Abbott Product Table 76. Abbott Recent Development Table 77. Novartis Corporation Information Table 78. Novartis Description and Business Overview Table 79. Novartis Risedronate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 80. Novartis Product Table 81. Novartis Recent Development Table 82. Tecoland Corporation Information Table 83. Tecoland Description and Business Overview Table 84. Tecoland Risedronate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 85. Tecoland Product Table 86. Tecoland Recent Development Table 87. Taj Pharmaceuticals Corporation Information Table 88. Taj Pharmaceuticals Description and Business Overview Table 89. Taj Pharmaceuticals Risedronate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 90. Taj Pharmaceuticals Product Table 91. Taj Pharmaceuticals Recent Development Table 92. Key Raw Materials Lists Table 93. Raw Materials Key Suppliers Lists Table 94. Risedronate Customers List Table 95. Risedronate Distributors List Table 96. Research Programs/Design for This Report Table 97. Key Data Information from Secondary Sources Table 98. Key Data Information from Primary Sources List of Figures Figure 1. Risedronate Product Picture Figure 2. Global Risedronate Revenue, (US$ Million), 2017 VS 2022 VS 2028 Figure 3. Global Risedronate Market Size 2017-2028 (US$ Million) Figure 4. Global Risedronate Sales 2017-2028 (MT) Figure 5. United States Risedronate Revenue, (US$ Million), 2017 VS 2022 VS 2028 Figure 6. United States Risedronate Market Size 2017-2028 (US$ Million) Figure 7. United States Risedronate Sales 2017-2028 (MT) Figure 8. United States Risedronate Market Share in Global, in Value (US$ Million) 2017-2028 Figure 9. United States Risedronate Market Share in Global, in Volume (MT) 2017-2028 Figure 10. Risedronate Report Years Considered Figure 11. Product Picture of 5 mg Tablets Figure 12. Product Picture of 35 mg Tablets Figure 13. Product Picture of 75 mg Tablets Figure 14. Product Picture of 150 mg Tablets Figure 15. Global Risedronate Market Share by Type in 2022 & 2028 Figure 16. Global Risedronate Sales in Value by Type (2017-2028) & (US$ Million) Figure 17. Global Risedronate Sales Market Share in Value by Type (2017-2028) Figure 18. Global Risedronate Sales by Type (2017-2028) & (MT) Figure 19. Global Risedronate Sales Market Share in Volume by Type (2017-2028) Figure 20. Global Risedronate Price by Type (2017-2028) & (USD/Kg) Figure 21. United States Risedronate Market Share by Type in 2022 & 2028 Figure 22. United States Risedronate Sales in Value by Type (2017-2028) & (US$ Million) Figure 23. United States Risedronate Sales Market Share in Value by Type (2017-2028) Figure 24. United States Risedronate Sales by Type (2017-2028) & (MT) Figure 25. United States Risedronate Sales Market Share in Volume by Type (2017-2028) Figure 26. United States Risedronate Price by Type (2017-2028) & (USD/Kg) Figure 27. Product Picture of Postmenopausal Osteoporosis Figure 28. Product Picture of Men with Osteoporosis Figure 29. Global Risedronate Market Share by Application in 2022 & 2028 Figure 30. Global Risedronate Sales in Value by Application (2017-2028) & (US$ Million) Figure 31. Global Risedronate Sales Market Share in Value by Application (2017-2028) Figure 32. Global Risedronate Sales by Application (2017-2028) & (MT) Figure 33. Global Risedronate Sales Market Share in Volume by Application (2017-2028) Figure 34. Global Risedronate Price by Application (2017-2028) & (USD/Kg) Figure 35. United States Risedronate Market Share by Application in 2022 & 2028 Figure 36. United States Risedronate Sales in Value by Application (2017-2028) & (US$ Million) Figure 37. United States Risedronate Sales Market Share in Value by Application (2017-2028) Figure 38. United States Risedronate Sales by Application (2017-2028) & (MT) Figure 39. United States Risedronate Sales Market Share in Volume by Application (2017-2028) Figure 40. United States Risedronate Price by Application (2017-2028) & (USD/Kg) Figure 41. North America Risedronate Sales in Volume Growth Rate 2017-2028 (MT) Figure 42. North America Risedronate Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 43. U.S. Risedronate Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 44. Canada Risedronate Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 45. Europe Risedronate Sales in Volume Growth Rate 2017-2028 (MT) Figure 46. Europe Risedronate Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 47. Germany Risedronate Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 48. France Risedronate Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 49. U.K. Risedronate Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 50. Italy Risedronate Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 51. Russia Risedronate Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 52. Asia-Pacific Risedronate Sales in Volume Growth Rate 2017-2028 (MT) Figure 53. Asia-Pacific Risedronate Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 54. China Risedronate Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 55. Japan Risedronate Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 56. South Korea Risedronate Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 57. India Risedronate Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 58. Australia Risedronate Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 59. Taiwan Risedronate Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 60. Indonesia Risedronate Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 61. Thailand Risedronate Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 62. Malaysia Risedronate Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 63. Philippines Risedronate Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 64. Latin America Risedronate Sales in Volume Growth Rate 2017-2028 (MT) Figure 65. Latin America Risedronate Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 66. Mexico Risedronate Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 67. Brazil Risedronate Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 68. Argentina Risedronate Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 69. Middle East & Africa Risedronate Sales in Volume Growth Rate 2017-2028 (MT) Figure 70. Middle East & Africa Risedronate Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 71. Turkey Risedronate Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 72. Saudi Arabia Risedronate Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 73. U.A.E Risedronate Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 74. Risedronate Value Chain Figure 75. Risedronate Production Process Figure 76. Channels of Distribution Figure 77. Distributors Profiles Figure 78. Bottom-up and Top-down Approaches for This Report Figure 79. Data Triangulation Figure 80. Key Executives Interviewed
Merck Amgen Teva Mylan Apotex Sanofi Abbott Novartis Tecoland Taj Pharmaceuticals
Personalized Cancer Medicine market is segmented by region (country), players, by Type and by App ... Read More
Artificial Intelligence in Precision Medicine market is segmented by region (country), players, b ... Read More
Chromosome Enumeration Probes (CEP) market is segmented by region (country), players, by Type and ... Read More
Hematology Probes market is segmented by region (country), players, by Type and by Application. P ... Read More